Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.

The aim of this study was to map the microbiota distribution along the gut and establish whether colon/faecal samples from diabetic rats adequately reflect the diabetic alterations in the microbiome. Streptozotocin-treated rats were used to model type 1 diabetes mellitus (T1D). Segments of the duode...

Full description

Bibliographic Details
Main Authors: Roland Wirth, Nikolett Bódi, Gergely Maróti, Mária Bagyánszki, Petra Talapka, Éva Fekete, Zoltán Bagi, Kornél L Kovács
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4254516?pdf=render
_version_ 1818384806850854912
author Roland Wirth
Nikolett Bódi
Gergely Maróti
Mária Bagyánszki
Petra Talapka
Éva Fekete
Zoltán Bagi
Kornél L Kovács
author_facet Roland Wirth
Nikolett Bódi
Gergely Maróti
Mária Bagyánszki
Petra Talapka
Éva Fekete
Zoltán Bagi
Kornél L Kovács
author_sort Roland Wirth
collection DOAJ
description The aim of this study was to map the microbiota distribution along the gut and establish whether colon/faecal samples from diabetic rats adequately reflect the diabetic alterations in the microbiome. Streptozotocin-treated rats were used to model type 1 diabetes mellitus (T1D). Segments of the duodenum, ileum and colon were dissected, and the microbiome of the lumen material was analysed by using next-generation DNA sequencing, from phylum to genus level. The intestinal luminal contents were compared between diabetic, insulin-treated diabetic and healthy control rats. No significant differences in bacterial composition were found in the luminal contents from the duodenum of the experimental animal groups, whereas distinct patterns were seen in the ileum and colon, depending on the history of the luminal samples. Ileal samples from diabetic rats exhibited particularly striking alterations, while the richness and diversity obscured some of the modifications in the colon. Characteristic rearrangements in microbiome composition and diversity were detected after insulin treatment, though the normal gut flora was not restored. The Proteobacteria displayed more pronounced shifts than those of the predominant phyla (Firmicutes and Bacteroidetes) in the rat model of T1D. Diabetes and insulin replacement affect the composition of the gut microbiota in different, gut region-specific manners. The luminal samples from the ileum appear more suitable for diagnostic purposes than the colon/faeces. The Proteobacteria should be at the focus of diagnosis and potential therapy. Klebsiella are recommended as biomarkers of T1D.
first_indexed 2024-12-14T03:28:07Z
format Article
id doaj.art-65c54ace5eff47168b589a596c7229f2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T03:28:07Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-65c54ace5eff47168b589a596c7229f22022-12-21T23:18:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11044010.1371/journal.pone.0110440Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.Roland WirthNikolett BódiGergely MarótiMária BagyánszkiPetra TalapkaÉva FeketeZoltán BagiKornél L KovácsThe aim of this study was to map the microbiota distribution along the gut and establish whether colon/faecal samples from diabetic rats adequately reflect the diabetic alterations in the microbiome. Streptozotocin-treated rats were used to model type 1 diabetes mellitus (T1D). Segments of the duodenum, ileum and colon were dissected, and the microbiome of the lumen material was analysed by using next-generation DNA sequencing, from phylum to genus level. The intestinal luminal contents were compared between diabetic, insulin-treated diabetic and healthy control rats. No significant differences in bacterial composition were found in the luminal contents from the duodenum of the experimental animal groups, whereas distinct patterns were seen in the ileum and colon, depending on the history of the luminal samples. Ileal samples from diabetic rats exhibited particularly striking alterations, while the richness and diversity obscured some of the modifications in the colon. Characteristic rearrangements in microbiome composition and diversity were detected after insulin treatment, though the normal gut flora was not restored. The Proteobacteria displayed more pronounced shifts than those of the predominant phyla (Firmicutes and Bacteroidetes) in the rat model of T1D. Diabetes and insulin replacement affect the composition of the gut microbiota in different, gut region-specific manners. The luminal samples from the ileum appear more suitable for diagnostic purposes than the colon/faeces. The Proteobacteria should be at the focus of diagnosis and potential therapy. Klebsiella are recommended as biomarkers of T1D.http://europepmc.org/articles/PMC4254516?pdf=render
spellingShingle Roland Wirth
Nikolett Bódi
Gergely Maróti
Mária Bagyánszki
Petra Talapka
Éva Fekete
Zoltán Bagi
Kornél L Kovács
Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.
PLoS ONE
title Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.
title_full Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.
title_fullStr Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.
title_full_unstemmed Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.
title_short Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.
title_sort regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin induced diabetes
url http://europepmc.org/articles/PMC4254516?pdf=render
work_keys_str_mv AT rolandwirth regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT nikolettbodi regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT gergelymaroti regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT mariabagyanszki regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT petratalapka regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT evafekete regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT zoltanbagi regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes
AT kornellkovacs regionallydistinctalterationsinthecompositionofthegutmicrobiotainratswithstreptozotocininduceddiabetes